This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Cell & Gene Therapy Manufacturing & Commercialization Europe

£400 Savings Expires in

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
5-8 December 2022
Beurs van BerlageAmsterdam, Netherlands

THE EUROPEAN CELL AND GENE THERAPY CONGRESS FOR GROUND BREAKING MANUFACTURING, COMMERCIALISATION & SUPPLY CHAIN STRATEGIES

World renowned leaders share the latest analytical techniques & vector technologies to revolutionise your cell, gene & gene edited ex vivo cell therapy programs

BRINGING YOU CUTTING EDGE CASE STUDIES TO IMPROVE EFFICIENCIES IN CELL & GENE THERAPY PRODUCTION

Cell Therapy

  • Discover process optimisation and implementation strategies for automated, closed and integrated systems in cell therapy manufacturing
  • Build your analytical toolbox to improve testing, characterisation & validation strategies
  • Get to grips with raw materials, cryopreservation, and logistical requirements for seamless end to end supply chains

Gene Edited Ex Vivo Cell Therapy

  • Build a strategy for the scale up and manufacturing of for next generation “off the shelf” allogeneic and gene edited modalities
  • Get to grips with manufacturing and commercialisation strategies for CAR-Ts, NK cells, TCRs, TILs and iPSCs products
  • Beyond rare diseases: Overcome the challenges of expanding to larger patient populations with cell and gene therapies

In Vivo Gene Therapy

  • Hear case studies on how to increase speed, consistency, scalability, and flexibility in gene therapy manufacturing
  • Discuss next generation non-viral gene editing techniques and their potential to transform the field
  • Develop analytical toolkits for AAV characterisation, validation and understanding CQAs

PRESENT A SCIENTIFIC POSTER AT Cell & Gene Therapy Manufacturing & Commercialization EU 2022 | Due 4 November 2022

Any registered All Access Pass attendee is eligible to register for a scientific poster space at no additional charge. All poster abstracts must be summited by 4 November 2022. For full poster specifications and to submit your poster abstract, click the button below. 

CONNECT WITH KEY BUYERS AT CELL & GENE THERAPY EUROPE 2022

Whether you're increasing your company profile, launching a new product or focusing on new business development opportunities, collaborate with us to identify custom solutions to help you reach your goals.  

Contact Perri Lucatello: PLucatello@informaconnectls.com | +44 (0)20 7017 7247